학술논문
Lower Fracture Rates in Patients Treated with Radium-223, Abiraterone or Enzalutamide, When Given Concurrently with Bone Health Agents: A Real-World Analysis
Document Type
Article
Author
Source
In Clinical Genitourinary Cancer October 2022 20(5):399-403
Subject
Language
ISSN
1558-7673